Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.25 CHF | -0.74% | -4.05% | +14.02% |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
Apr. 04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
Evolution of the average Target Price on Basilea Pharmaceutica AG
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Basilea Pharmaceutica AG
Edward Jones |
EPS Revisions
- Stock Market
- Equities
- BSLN Stock
- Consensus Basilea Pharmaceutica AG